The neuropathy associated with SPTLC1 mutation exhibited some improvement after supplementation with oral L-serine (Fridman et al., 2019), which also partially improved the symptoms of sensorimotor and autonomic neuropathy in our PSAT1-related patients. The gene discussed is SPTLC1; the disease is neuropathy.